QA: Nanoviricides INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2020_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 2,825,421
1 IntangibleAssetsNetIncludingGoodwill 366,658
2 PropertyPlantAndEquipmentNet 10,227,247
3 remainder_Assets 29,187
4 LiabilitiesCurrent 2,848,153
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,778,251
9 ResearchAndDevelopmentExpense 5,921,100
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 445,803
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 13,448,513
1 Liabilities 2,848,153
2 Expenses 8,699,351
3 Revenues 0
4 StockholdersEquity 10,600,360
5 NetIncome -8,253,548
6 ComprehensiveNetIncome -8,253,548
7 BaseVar 12,720,910
8 EconomicCapitalRatiobeforeLimitedLiability 1.82
9 EconomicCapitalRatio 2.90

Edgar->Model Mapping

Feature Distribution

Change over Time